Merial

Lilly picks up BI’s pet vaccines for $885M

Eli Lilly rocketed into the No. 3 spot among the world’s top animal health companies when it picked up Novartis Animal Health for $5.4 billion last year--and now it’s set to strengthen its position even more. The company’s Elanco division will acquire Boehringer Ingelheim’s dog and cat vaccines, along with a manufacturing and R&D site in Fort Dodge, Iowa, for $885 million.